Want to see SYRA full AI Analyst Report?
SYRA Stock Chart & Stats
$0.73
<$0.01(0.03%)
At close: 4:00 PM EDT
$0.73
<$0.01(0.03%)
Day’s Range― - ―
52-Week Range$0.05 - $1.15
Previous CloseN/A
Volume5.87K
Average Volume (3M)9.76K
Market Cap
$10.36M
Enterprise Value$3.39M
Total Cash (Recent Filing)$2.92M
Total Debt (Recent Filing)$73.09K
Price to Earnings (P/E)―
Beta0.88
Next Earnings
Aug 06, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding13,839,169
10 Day Avg. Volume11,249
30 Day Avg. Volume9,759
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.49
Price to Sales (P/S)0.14
P/FCF Ratio-2.28
Enterprise Value/Market Cap0.33
Enterprise Value/Revenue0.44
Enterprise Value/Gross Profit1.34
Enterprise Value/Ebitda-21.30
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Improving MarginsA multi-hundred-percent revenue rebound with ~33% gross margin and a move to positive operating and free cash flow indicates durable demand and improving unit economics. This supports reinvestment and scaling, and provides a structural foundation for sustained profitability if growth and margins persist.
Conservative Leverage And Stronger Balance SheetVery low debt-to-equity reduces financing risk and gives management flexibility to fund growth organically or via opportunistic M&A. A conservative capital structure is a lasting strength through cycles, improving resilience and lowering bankruptcy risk while preserving capacity to invest in strategic initiatives.
Governance Continuity And Expanded Retention CapacityRe-election of directors and auditor ratification sustain governance stability, supporting consistent strategic execution. Increasing the equity incentive pool strengthens the company's ability to retain and attract key clinical and technical talent, which is vital for long-term service delivery and product development.
Bears Say
Persisting Net Losses And Negative ReturnsDespite improvement, the business remains slightly loss-making with negative ROE, meaning capital has not yet generated positive shareholder returns. Continued unprofitability leaves the company dependent on continued top-line momentum or external funding to achieve durable shareholder value creation.
Historically Volatile Cash GenerationYear-to-year swings from large outflows to recent positive cash flow indicate inconsistent cash conversion. Such volatility hampers planning, raises refinancing risk if improvements reverse, and means recent positive FCF must be sustained over several quarters to be deemed reliable.
Dilution Risk From Larger Equity Incentive PlanExpanding the equity incentive pool improves retention but introduces structural dilution risk for existing shareholders. Over time, issuance to employees or directors can dilute per-share earnings and equity value, potentially offsetting benefits of talent alignment if share-based compensation is a major recurring expense.
Syra Health Corp. Class A News
SYRA FAQ
What was Syra Health Corp. Class A’s price range in the past 12 months?
Syra Health Corp. Class A lowest stock price was $0.05 and its highest was $1.15 in the past 12 months.
What is Syra Health Corp. Class A’s market cap?
Syra Health Corp. Class A’s market cap is $10.36M.
When is Syra Health Corp. Class A’s upcoming earnings report date?
Syra Health Corp. Class A’s upcoming earnings report date is Aug 06, 2026 which is in 4 days.
How were Syra Health Corp. Class A’s earnings last quarter?
Syra Health Corp. Class A released its earnings results on May 07, 2026. The company reported $0.019 earnings per share for the quarter, beating the consensus estimate of N/A by $0.019.
Is Syra Health Corp. Class A overvalued?
According to Wall Street analysts Syra Health Corp. Class A’s price is currently Overvalued.
Does Syra Health Corp. Class A pay dividends?
Syra Health Corp. Class A does not currently pay dividends.
What is Syra Health Corp. Class A’s EPS estimate?
Syra Health Corp. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syra Health Corp. Class A have?
Syra Health Corp. Class A has 13,839,169 shares outstanding.
What happened to Syra Health Corp. Class A’s price movement after its last earnings report?
Syra Health Corp. Class A reported an EPS of $0.019 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 11.111%.
Which hedge fund is a major shareholder of Syra Health Corp. Class A?
Currently, no hedge funds are holding shares in SYRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Syra Health Corp. Class A
Syra Health Corp. is a U.S.-based healthcare services company offering a diverse portfolio of solutions. Their core offerings span health education, population health management, behavioral and mental health support, healthcare workforce solutions, and digital health advancements. Within health education, the company provides medical communications, patient-focused learning programs, and professional training. Its population health management segment features analytics-as-a-service, epidemiological studies, and health equity analysis tools. Additionally, Syra Health is actively developing "Syrenity," an on-demand telehealth platform specifically designed for mental health services. The firm further extends its reach through healthcare staffing provisions and comprehensive digital health solutions. These digital solutions encompass digital transformation initiatives, cloud and cybersecurity services, artificial intelligence applications, patient engagement tools, and various health-related mobile applications. Syra Health serves a broad spectrum of clients, including mental health facilities and organizations, government entities, integrated health networks, managed care organizations, and pharmaceutical manufacturers. Established in 2020, the company's headquarters are located in Carmel, Indiana.
Technical Analysis
American Shared Hospital Services
―
Concord Medical Services
―
―
Cryo-Cell International
―
P3 Health Partners
―